MedTrace Logo

Alcohol and "Heat of the Moment" Sexual Decision Making

NCT05729256 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 354

Last updated 2025-02-07

No results posted yet for this study

Summary

HIV transmission remains a significant public health concern, especially among men who have sex with men (MSM). Condomless anal intercourse (CAI) continues to be the major route of transmission for MSM. Thus, to reduce the incidence of HIV, it is critical to identify how contextual risk factors influence CAI and develop behavioral strategies that modify risk factors directly or reduce their influence on behavior. This study will examine the mechanisms through which one of the central contextual risk factors, heavy drinking, influences sexual decision processes in the natural environment and test the benefit of a brief intervention designed to reduce sexual risk behavior among those who engage in heavy drinking.

Conditions

  • Alcohol Drinking
  • Sex, Unsafe
  • Hiv

Interventions

BEHAVIORAL

Self-Regulation Intervention

Single session motivational intervention on reducing heavy drinking and sexual risk behavior, encouraging consideration of pre-exposure prophylaxis (PrEP), followed by 4 weeks of text messages on content relevant to drinking goals and support for healthy sexual choices

BEHAVIORAL

Brief Advice and Information

Psychoeducation about heavy drinking risks, discussion of barriers to safe sex, information about pre-exposure prophylaxis (PrEP)

Sponsors & Collaborators

  • Syracuse University

    collaborator OTHER

  • University of South Dakota

    collaborator OTHER

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • Boston University Charles River Campus

    lead OTHER

Principal Investigators

  • Tibor Palfai, PhD · Boston University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2026-09-30
Completion
2026-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05729256 on ClinicalTrials.gov